ID26223A - VITRONEKTIN RECEPTOR ANTAGONISTS - Google Patents
VITRONEKTIN RECEPTOR ANTAGONISTSInfo
- Publication number
- ID26223A ID26223A IDW20001737A ID20001737A ID26223A ID 26223 A ID26223 A ID 26223A ID W20001737 A IDW20001737 A ID W20001737A ID 20001737 A ID20001737 A ID 20001737A ID 26223 A ID26223 A ID 26223A
- Authority
- ID
- Indonesia
- Prior art keywords
- vitronektin
- receptor antagonists
- antagonists
- receptor
- vitronektin receptor
- Prior art date
Links
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7761098P | 1998-03-10 | 1998-03-10 | |
| US9606398P | 1998-08-11 | 1998-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID26223A true ID26223A (en) | 2000-12-07 |
Family
ID=26759473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20001737A ID26223A (en) | 1998-03-10 | 1999-03-10 | VITRONEKTIN RECEPTOR ANTAGONISTS |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1061921A4 (en) |
| JP (1) | JP2002506033A (en) |
| KR (1) | KR20010041812A (en) |
| CN (1) | CN1299282A (en) |
| AP (1) | AP2000001898A0 (en) |
| AR (1) | AR015241A1 (en) |
| AU (1) | AU758498B2 (en) |
| BG (1) | BG104824A (en) |
| BR (1) | BR9908636A (en) |
| CA (1) | CA2323208A1 (en) |
| CO (1) | CO5080762A1 (en) |
| DZ (1) | DZ2741A1 (en) |
| EA (1) | EA200000921A1 (en) |
| HU (1) | HUP0101143A3 (en) |
| ID (1) | ID26223A (en) |
| IL (1) | IL138245A0 (en) |
| NO (1) | NO20004503L (en) |
| OA (1) | OA12189A (en) |
| PE (1) | PE20000323A1 (en) |
| PL (1) | PL342881A1 (en) |
| SK (1) | SK13292000A3 (en) |
| TR (1) | TR200002625T2 (en) |
| UY (2) | UY25421A1 (en) |
| WO (1) | WO1999045927A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19939980A1 (en) | 1999-08-24 | 2001-03-01 | Merck Patent Gmbh | Inhibitors of the integrin alphavbeta¶3¶ |
| DE19939981A1 (en) * | 1999-08-24 | 2001-03-01 | Merck Patent Gmbh | New inhibitors of the integrin alphavß3 |
| US6881736B1 (en) | 1999-09-07 | 2005-04-19 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
| EG24179A (en) * | 1999-09-07 | 2008-09-28 | Smithkline Beecham Corp | Vitronectin receptor antagonists |
| US6448278B2 (en) | 1999-12-23 | 2002-09-10 | Pfizer Inc. | Procollagen C-proteinase inhibitors |
| GB9930570D0 (en) * | 1999-12-23 | 2000-02-16 | Pfizer Ltd | Therapy |
| FR2808798A1 (en) * | 2000-05-09 | 2001-11-16 | Hoechst Marion Roussel Inc | New N-heterocyclyl-aminoacid derivatives and analogs, are vitronectin analogs useful e.g. for treating osteoporosis, tumor growth or metastasis, inflammation or cardiovascular disease |
| WO2001096307A2 (en) | 2000-06-15 | 2001-12-20 | Pharmacia Corporation | Cycloalkyl alkanoic acids as integrin receptor antagonists |
| US6531494B1 (en) | 2001-08-29 | 2003-03-11 | Pharmacia Corporation | Gem-substituted αvβ3 antagonists |
| US6645993B2 (en) | 2001-03-30 | 2003-11-11 | Warner-Lambert Company | 3-heterocyclylpropanohydroxamic acid PCP inhibitors |
| US6716842B2 (en) | 2002-04-05 | 2004-04-06 | Warner-Lambert Company, Llc | Antidiabetic agents |
| US20070275956A1 (en) * | 2003-10-14 | 2007-11-29 | Lohray Braj B | Novel Heterocyclic Compounds |
| US7678810B2 (en) * | 2004-03-05 | 2010-03-16 | Taisho Pharmaceutical Co., Ltd | Thiazole derivative |
| UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| WO2006115652A1 (en) | 2005-04-20 | 2006-11-02 | Janssen Pharmaceutica, N.V. | Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls |
| PL3040329T3 (en) * | 2013-08-29 | 2019-04-30 | Kyoto Pharma Ind | Aromatic compound and use thereof in the treatment of disorders associated with bone metabolism |
| EP3050878B1 (en) | 2013-09-24 | 2021-10-27 | FUJIFILM Corporation | Novel nitrogen-containing compound or salt thereof, or metal complex thereof |
| ES2864079T3 (en) | 2014-05-30 | 2021-10-13 | Pfizer | Carbonitrile derivatives as selective androgen receptor modulators |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR19990076877A (en) * | 1995-12-29 | 1999-10-25 | 스티븐 베네티아너 | Bitronectin receptor antagonist |
| CN1209060A (en) * | 1995-12-29 | 1999-02-24 | 史密丝克莱恩比彻姆公司 | vitronectin receptor antagonist |
-
1999
- 1999-03-10 DZ DZ990042A patent/DZ2741A1/en active
- 1999-03-10 SK SK1329-2000A patent/SK13292000A3/en unknown
- 1999-03-10 AP APAP/P/2000/001898A patent/AP2000001898A0/en unknown
- 1999-03-10 CA CA002323208A patent/CA2323208A1/en not_active Abandoned
- 1999-03-10 PL PL99342881A patent/PL342881A1/en unknown
- 1999-03-10 JP JP2000535342A patent/JP2002506033A/en not_active Withdrawn
- 1999-03-10 AR ARP990101019A patent/AR015241A1/en not_active Application Discontinuation
- 1999-03-10 IL IL13824599A patent/IL138245A0/en unknown
- 1999-03-10 CO CO99014712A patent/CO5080762A1/en unknown
- 1999-03-10 OA OA00000248A patent/OA12189A/en unknown
- 1999-03-10 HU HU0101143A patent/HUP0101143A3/en unknown
- 1999-03-10 PE PE1999000188A patent/PE20000323A1/en not_active Application Discontinuation
- 1999-03-10 WO PCT/US1999/005232 patent/WO1999045927A1/en not_active Ceased
- 1999-03-10 AU AU29033/99A patent/AU758498B2/en not_active Ceased
- 1999-03-10 ID IDW20001737A patent/ID26223A/en unknown
- 1999-03-10 BR BR9908636-0A patent/BR9908636A/en not_active Application Discontinuation
- 1999-03-10 KR KR1020007010091A patent/KR20010041812A/en not_active Withdrawn
- 1999-03-10 EP EP99909952A patent/EP1061921A4/en not_active Withdrawn
- 1999-03-10 UY UY25421A patent/UY25421A1/en unknown
- 1999-03-10 EA EA200000921A patent/EA200000921A1/en unknown
- 1999-03-10 CN CN99805833A patent/CN1299282A/en active Pending
- 1999-03-10 TR TR2000/02625T patent/TR200002625T2/en unknown
- 1999-05-19 UY UY25519A patent/UY25519A1/en unknown
-
2000
- 2000-09-08 NO NO20004503A patent/NO20004503L/en unknown
- 2000-10-03 BG BG104824A patent/BG104824A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AP2000001898A0 (en) | 2000-09-30 |
| CN1299282A (en) | 2001-06-13 |
| UY25421A1 (en) | 2001-07-31 |
| AR015241A1 (en) | 2001-04-18 |
| JP2002506033A (en) | 2002-02-26 |
| CO5080762A1 (en) | 2001-09-25 |
| PL342881A1 (en) | 2001-07-16 |
| AU2903399A (en) | 1999-09-27 |
| BG104824A (en) | 2001-05-31 |
| NO20004503D0 (en) | 2000-09-08 |
| OA12189A (en) | 2006-05-09 |
| CA2323208A1 (en) | 1999-09-16 |
| DZ2741A1 (en) | 2003-09-08 |
| KR20010041812A (en) | 2001-05-25 |
| AU758498B2 (en) | 2003-03-20 |
| EA200000921A1 (en) | 2001-04-23 |
| HUP0101143A2 (en) | 2001-08-28 |
| SK13292000A3 (en) | 2001-06-11 |
| BR9908636A (en) | 2002-01-08 |
| EP1061921A1 (en) | 2000-12-27 |
| WO1999045927A1 (en) | 1999-09-16 |
| TR200002625T2 (en) | 2000-12-21 |
| UY25519A1 (en) | 1999-12-13 |
| HUP0101143A3 (en) | 2002-12-28 |
| PE20000323A1 (en) | 2000-05-24 |
| EP1061921A4 (en) | 2005-03-30 |
| NO20004503L (en) | 2000-10-10 |
| IL138245A0 (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID19623A (en) | VITRONEKTIN RECEPTOR ANTAGONISTS | |
| ATE280157T1 (en) | 4-AROYL-PIPERIDINE-CCR-3 RECEPTOR ANTAGONISTS III | |
| DE69812096D1 (en) | NEUROPEPTID Y RECEPTOR ANTAGONISTS | |
| NO20012411D0 (en) | Pyrrolidine derivatives-CCR-3 receptor antagonists | |
| IS5706A (en) | Adenosine A3 receptor antagonists | |
| DK1009732T3 (en) | 1-Amino-alkylcyclohexane NMDA receptor antagonists | |
| DE69905248T2 (en) | NEUROPEPTIDE Y5 RECEPTOR ANTAGONISTS | |
| EP0986385A4 (en) | GONADOLIBERINE ANTAGONISTS | |
| ID18003A (en) | MUSCARINIC ANTAGONISTS | |
| NO993586D0 (en) | K-8 receptor antagonists | |
| ID16742A (en) | ENDOTELIN RECEPTOR ANTAGONISTS | |
| ID24726A (en) | TROMBIN RECEPTOR ANTAGONISTS | |
| EP0885205A4 (en) | FIBRINOGENIC RECEPTOR ANTAGONISTS | |
| DE69919171D1 (en) | MUSCARINE RECEPTOR ANTAGONISTS | |
| ID24162A (en) | VITRONECTTIN RECEPTOR ANTAGONISTS | |
| NO20015779D0 (en) | Bradykinin receptor antagonists | |
| NO20004503L (en) | Vitronectin receptor antagonists | |
| ID26665A (en) | VLA-4 ANTAGONISTS | |
| TR199501389A2 (en) | Adesion receptor antagonists (counterparts). | |
| ID22838A (en) | OKSAZOLIDINA AS 5-HT2A ANTAGONISTS | |
| ID28811A (en) | VITRONEKTIN RECEPTOR ANTAGONISTS | |
| ID24468A (en) | 2-ACYLAMINOPROPANAMINA AS TACHYKININ RECEPTOR ANTAGONISTS | |
| ID27845A (en) | TETRAHIDROKUILINA DECREASED AS GLISILINA ANTAGONISTS | |
| ID24309A (en) | 2-ACYLAMINOPROPANAMINA AS TACHYKININ RECEPTOR ANTAGONISTS | |
| NO20010620D0 (en) | Vitronectin receptor antagonists |